ulcerative colitis

Early changes in the pharmacokinetic profile of vedolizumab-treated patients with IBD may predict response after dose optimisation
Célia Gouynou, Lieven Pouillon, Hélène Rousseau, Camille Zallot, Cédric Baumann, Laurent Peyrin-Biroulet

Gut Jan 2019, 68 (1) 178-179; DOI: 10.1136/gutjnl-2017-315766
Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease
Sebastian Zeissig, Elisa Rosati, C Marie Dowds, Konrad Aden, Johannes Bethge, Berenice Schulte, Wei Hung Pan, Neha Mishra, Maaz Zuhayra, Marlies Marx, Maren Paulsen, Anne Strigli, Claudio Conrad, Dörthe Schuldt, Anupam Sinha, Henriette Ebsen, Sabin-Christin Kornell, Susanna Nikolaus, Alexander Arlt, Dieter Kabelitz, Mark Ellrichmann, Ulf Lützen, Philip C Rosenstiel, Andre Franke, Stefan Schreiber

Gut Jan 2019, 68 (1) 25-39; DOI: 10.1136/gutjnl-2018-316023
Which way does the axis tip? IBD increases the risk of Parkinson’s disease
Susan Hutfless, Gregor K Wenning

Gut Jan 2019, 68 (1) 3; DOI: 10.1136/gutjnl-2018-316537
Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide population-based cohorts
Ryan C Ungaro, Berkeley N Limketkai, Camilla Bjørn Jensen, Kristine Højgaard Allin, Manasi Agrawal, Thomas Ullman, Jean-Frederic Colombel, Tine Jess

Gut Nov 2018, gutjnl-2018-317021; DOI: 10.1136/gutjnl-2018-317021
Definitions of response and remission for the Robarts Histopathology Index
Rish K Pai, Reena Khanna, Geert R D’Haens, William J Sandborn, Jenny Jeyarajah, Brian G Feagan, Niels Vande Casteele, Vipul Jairath

Gut Oct 2018, gutjnl-2018-317547; DOI: 10.1136/gutjnl-2018-317547
Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression
Alexandra D Frolkis, Isabelle A Vallerand, Abdel-Aziz Shaheen, Mark W Lowerison, Mark G Swain, Cheryl Barnabe, Scott B Patten, Gilaad G Kaplan

Gut Oct 2018, gutjnl-2018-317182; DOI: 10.1136/gutjnl-2018-317182
Rare cause of rectal stenosis in a patient with long-term use of Infliximab and Mercaptopurine for ulcerative colitis
Nassim Hammoudi, Charlotte Gardair, My-Linh Tran-Minh, Matthieu Allez, Jean-Marc Gornet

Gut Oct 2018, gutjnl-2018-317069; DOI: 10.1136/gutjnl-2018-317069
Authors’ response: Association between IBD and Parkinson’s disease: seek and you shall find?
Marie Villumsen, Susana Aznar, Bente Pakkenberg, Tomasz Brudek, Tine Jess

Gut Aug 2018, gutjnl-2018-317336; DOI: 10.1136/gutjnl-2018-317336
Oral vancomycin induces clinical and mucosal remission of colitis in children with primary sclerosing cholangitis–ulcerative colitis
Li-Zsa Tan, Claire R Reilly, Lana C Steward-Harrison, Fariha Balouch, Richard Muir, Peter J Lewindon

Gut Aug 2018, gutjnl-2018-316599; DOI: 10.1136/gutjnl-2018-316599
Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trial
Vipul Jairath, Laurent Peyrin-Biroulet, Guangyong Zou, Mahmoud Mosli, Niels Vande Casteele, Reetesh K Pai, Mark A Valasek, Aude Marchal-Bressenot, Larry W Stitt, Lisa M Shackelton, Reena Khanna, Geert R D’Haens, William J Sandborn, Allan Olson, Brian G Feagan, Rish K Pai

Gut Aug 2018, gutjnl-2018-316702; DOI: 10.1136/gutjnl-2018-316702

Main menu

ulcerative colitis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

ulcerative colitis

Pages